台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    92.0
  • 漲跌
    ▼0.5
  • 漲幅
    -0.54%
  • 成交量
    125
  • 產業
    上市 生技醫療類股▲1.42%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
旭富 (4119)籌碼相關-富邦-和美 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-和美 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/160.191.50191.5092.50-0.9225-0.40%
2024/05/13191.9000.0091.8012320.43%
2024/05/060.188.6000.0088.500.12420.02%
2024/04/26188.8000.0089.0012450.41%
2024/04/17187.9000.0088.4012490.40%
2024/03/21187.70087.8087.7012740.36%
2024/03/20287.5500.0087.6022780.72%
2024/03/1900.000.288.0087.90-0.2280-0.08%
2024/03/1200.00089.5089.0002780.00%
2024/02/29191.3000.0091.2012810.36%
2024/02/2600.00192.0092.10-1283-0.35%
2024/02/1900.00091.5091.5002850.00%
2024/02/1600.000.191.1090.60-0.1285-0.04%
2024/02/02190.2000.0090.8012900.34%
2024/01/18194.5000.0094.3013110.32%
2024/01/11196.4000.0096.8013090.32%
2024/01/09297.3000.0097.3023170.63%
2024/01/08199.1000.0099.1013150.32%
2024/01/0500.00498.90100.00-4317-1.26%
2023/12/2800.000.296.9596.70-0.2314-0.06%
2023/12/2700.00197.2097.10-1314-0.32%
2023/12/26397.1700.0097.3033140.96%
2023/12/25296.4000.0096.3023110.64%
2023/12/2000.00197.5097.70-1307-0.33%
2023/12/19196.6000.0096.7013030.33%
2023/12/18196.0000.0097.5013020.33%
2023/12/140.294.100.194.8094.600.12890.03%
2023/12/12193.0000.0093.3012790.36%
2023/12/11191.8000.0092.3012750.36%
2023/11/2700.00092.5090.8002610.00%
2023/11/150.287.7300.0087.500.22450.08%
2023/11/130.288.4000.0088.200.22330.09%
2023/10/31190.6000.0089.4012020.49%
2023/10/2600.00190.0090.00-1200-0.50%
2023/10/1100.001100.0097.30-1221-0.45%
2023/10/06199.6000.0098.9012230.45%
2023/09/2100.00194.9094.00-1280-0.36%
2023/09/04199.7000.0099.6012980.33%
2023/08/311100.0000.0099.5013010.33%
2023/08/242100.0000.0099.8023040.66%
2023/08/1000.003105.00104.50-3343-0.87%
2023/08/0900.001103.00104.50-1370-0.27%
2023/08/041104.0000.00105.0013840.26%
2023/07/2800.001105.00105.00-1400-0.25%
2023/07/271.1105.5200.00105.001.14050.26%
2023/07/251114.0000.00114.5013970.25%
2023/07/142110.0000.00108.0024530.44%
2023/07/1200.008104.00104.00-8464-1.72%
2023/07/1100.005107.50107.50-5462-1.08%
2023/07/1000.001112.00108.50-1470-0.21%
2023/07/071117.5000.00116.5014500.22%
2023/07/051117.5000.00117.0014640.22%
2023/06/301119.0000.00118.5014880.20%
2023/06/2100.001116.50116.50-1534-0.19%
2023/06/200.2119.0000.00117.000.25370.04%
2023/06/161119.5000.00120.0015420.18%
2023/06/1400.001117.00116.50-1554-0.18%
2023/06/1300.001117.00117.00-1589-0.17%
2023/06/120.1116.5000.00116.500.16430.02%
2023/06/0900.001117.00117.00-1695-0.14%
2023/06/051117.0000.00117.0017450.13%
2023/05/312118.0000.00118.0027820.26%
2023/05/301116.5000.00116.5017870.13%
2023/05/151120.0000.00116.5018750.11%
2023/05/051129.5000.00128.5018660.12%
2023/05/0400.000.2130.00130.00-0.2863-0.02%
2023/04/1900.000.1132.50132.50-0.1796-0.01%
2023/04/172129.001130.00129.0017800.13%
2023/04/141128.002126.50128.50-1769-0.13%
2023/04/1100.001124.00124.00-1749-0.13%
2023/04/101120.0000.00121.5017370.14%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章